BPIM
Brant Point Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,936
| Closed | -$2.82M | – | 80 |
|
|
2023
Q4 | $2.82M | Buy |
11,936
+1,385
| +13% | +$327K | 0.23% | 57 |
|
|
2023
Q3 | $2.07M | Sell |
10,551
-3,586
| -25% | -$703K | 0.19% | 64 |
|
|
2023
Q2 | $2.97M | Sell |
14,137
-46
| -0.3% | -$9.67K | 0.68% | 55 |
|
|
2023
Q1 | $2.86M | Sell |
14,183
-5,098
| -26% | -$1.03M | 0.48% | 56 |
|
|
2022
Q4 | $4.2M | Sell |
19,281
-2,317
| -11% | -$505K | 0.62% | 40 |
|
|
2022
Q3 | $4.25M | Buy |
21,598
+6,500
| +43% | +$1.28M | 0.62% | 39 |
|
|
2022
Q2 | $3.23M | Sell |
15,098
-6,902
| -31% | -$1.48M | 0.48% | 50 |
|
|
2022
Q1 | $6.25M | Buy |
22,000
+6,904
| +46% | +$1.96M | 0.71% | 35 |
|
|
2021
Q4 | $5.69M | Buy |
15,096
+48
| +0.3% | +$18.1K | 0.89% | 40 |
|
|
2021
Q3 | $6.21M | Buy |
15,048
+48
| +0.3% | +$19.8K | 0.54% | 33 |
|
|
2021
Q2 | $5.55M | Hold |
15,000
| – | – | 0.51% | 45 |
|
|
2021
Q1 | $4.35M | Hold |
15,000
| – | – | 0.47% | 58 |
|
|
2020
Q4 | $3.75M | Buy |
15,000
+10,000
| +200% | +$2.5M | 0.44% | 60 |
|
|
2020
Q3 | $1.13M | Hold |
5,000
| – | – | 0.1% | 98 |
|
|
2020
Q2 | $872K | Buy |
+5,000
| New | +$872K | 0.09% | 96 |
|
|
2019
Q2 | – | Sell |
-19,800
| Closed | -$2.88M | – | 105 |
|
|
2019
Q1 | $2.88M | Buy |
+19,800
| New | +$2.88M | 0.36% | 65 |
|
|
2017
Q4 | – | Sell |
-38,800
| Closed | -$4.19M | – | 116 |
|
|
2017
Q3 | $4.19M | Sell |
38,800
-10,600
| -21% | -$1.14M | 0.44% | 55 |
|
|
2017
Q2 | $5M | Sell |
49,400
-18,700
| -27% | -$1.89M | 0.61% | 44 |
|
|
2017
Q1 | $6.13M | Buy |
+68,100
| New | +$6.13M | 0.63% | 32 |
|